Spencer J. Collis

Weston Park Cancer Centre
Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications

Race and "omic" data in glioma: A systematic review of contemporary research to explore the digital divide.

Race and "omic" data in glioma: A systematic review of contemporary research to explore the digital divide.

Journal: Neuro-oncology practice
Published: August 15, 2025

ATM inhibition increases the anti-tumor efficacy of radium-223 (Ra-223) against prostate cancer bone metastasis in preclinical models.

ATM inhibition increases the anti-tumor efficacy of radium-223 (Ra-223) against prostate cancer bone metastasis in preclinical models.

Journal: JBMR plus
Published: March 11, 2025

ARHGAP12 and ARHGAP29 exert distinct regulatory effects on switching between two cell morphological states through GSK-3 activity.

ARHGAP12 and ARHGAP29 exert distinct regulatory effects on switching between two cell morphological states through GSK-3 activity.

Journal: Cell reports
Published: February 16, 2024

Development and Optimisation of Tumour Treating Fields (TTFields) Delivery within 3D Primary Glioma Stem Cell-like Models of Spatial Heterogeneity.

Development and Optimisation of Tumour Treating Fields (TTFields) Delivery within 3D Primary Glioma Stem Cell-like Models of Spatial Heterogeneity.

Journal: Cancers
Published: January 17, 2024

SENP3-FIS1 axis promotes mitophagy and cell survival under hypoxia.

SENP3-FIS1 axis promotes mitophagy and cell survival under hypoxia.

Journal: Cell death & disease
Published: January 17, 2024

Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis.

Inhibition of ATR opposes glioblastoma invasion through disruption of cytoskeletal networks and integrin internalization via macropinocytosis.

Journal: Neuro-oncology
Published: November 08, 2023

Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients.

Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients.

Journal: F1000Research
Published: October 06, 2023

DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells.

DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells.

Journal: British journal of cancer
Published: June 03, 2023

Precision oncology using ex vivo technology: a step towards individualised cancer care?

Precision oncology using ex vivo technology: a step towards individualised cancer care?

Journal: Expert reviews in molecular medicine
Published: October 03, 2022

Development of a Personalised Device for Systemic Magnetic Drug Targeting to Brain Tumours.

Development of a Personalised Device for Systemic Magnetic Drug Targeting to Brain Tumours.

Journal: Nanotheranostics
Published: June 29, 2022

Correction: Tumour treating fields therapy for glioblastoma: current advances and future directions.

Correction: Tumour treating fields therapy for glioblastoma: current advances and future directions.

Journal: British journal of cancer
Published: June 11, 2021

DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.

DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies.

Journal: Molecular oncology
Published: April 06, 2021
Showing 1-12 of 26

Last Updated: 09/26/2026